168 related articles for article (PubMed ID: 8126890)
1. [Legionnaires' disease].
Toyoda K; Saito A
Nihon Rinsho; 1994 Feb; 52(2):384-8. PubMed ID: 8126890
[TBL] [Abstract][Full Text] [Related]
2. [Legionnaires' disease].
Koide M; Saito A
Nihon Rinsho; 2003 Feb; 61 Suppl 2():438-42. PubMed ID: 12722258
[No Abstract] [Full Text] [Related]
3. [Treatment of severe respiratory infection. Legionella pneumonia].
Saito A
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
[TBL] [Abstract][Full Text] [Related]
4. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia.
Varner TR; Bookstaver PB; Rudisill CN; Albrecht H
Ann Pharmacother; 2011 Jul; 45(7-8):967-76. PubMed ID: 21775694
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired Legionnaires' disease.
Muder RR; Yu VL; Fang GD
Semin Respir Infect; 1989 Mar; 4(1):32-9. PubMed ID: 2652233
[TBL] [Abstract][Full Text] [Related]
6. Treatment of legionnaires' disease.
Klein NC; Cunha BA
Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392
[TBL] [Abstract][Full Text] [Related]
7. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
8. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH
Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011
[TBL] [Abstract][Full Text] [Related]
10. [Pneumonia due to Legionella pneumophila in an immunocompromised child].
van Dijk K; Kamphuis S; Geelen SP; Wulffraat NM; van Gestel JP; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1420-3. PubMed ID: 12174438
[TBL] [Abstract][Full Text] [Related]
11. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
[No Abstract] [Full Text] [Related]
12. The treatment of Legionnaires' disease.
Dedicoat M; Venkatesan P
J Antimicrob Chemother; 1999 Jun; 43(6):747-52. PubMed ID: 10404312
[No Abstract] [Full Text] [Related]
13. [Diagnosis and treatment of legionella pneumonia].
Ewig S; Tuschy P; Fätkenheuer G
Pneumologie; 2002 Nov; 56(11):695-703. PubMed ID: 12442211
[TBL] [Abstract][Full Text] [Related]
14. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
[TBL] [Abstract][Full Text] [Related]
15. Legionella: macrolides or quinolones?
Pedro-Botet L; Yu VL
Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
[TBL] [Abstract][Full Text] [Related]
16. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Grau S; Antonio JM; Ribes E; Salvadó M; Garcés JM; Garau J
Int J Antimicrob Agents; 2006 Sep; 28(3):249-52. PubMed ID: 16870401
[TBL] [Abstract][Full Text] [Related]
17. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.
Mykietiuk A; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Infect Dis; 2005 Mar; 40(6):794-9. PubMed ID: 15736010
[TBL] [Abstract][Full Text] [Related]
20. Persistent culture-positive Legionella infection in an immunocompromised host.
O'Reilly KM; Urban MA; Barriero T; Betts RF; Trawick DR
Clin Infect Dis; 2005 May; 40(10):e87-9. PubMed ID: 15844057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
